The Oxycodone Hydrochloride Market Size is valued at USD 412.4 Mn in 2023 and is predicted to reach USD 572.8 Mn by the year 2031 at a 4.33% CAGR during the forecast period for 2024-2031.
Oxycodone hydrochloride is a prescribed opioid analgesic utilized for the management of moderate to severe pain, particularly when alternative analgesics, such as non-opioid medicines, prove inadequate. It functions by attaching to opioid receptors in the brain and spinal cord, modifying the experience of pain and the emotional response to it.
The rising incidence of chronic pain disorders is driving a notable expansion in the oxycodone hydrochloride industry. Many people throughout the world suffer from persistent discomfort, which is frequently brought on by serious medical conditions, including arthritis, cancer, and muscular problems. There is an increasing need for efficient pain management options as populations survive harder and greater numbers suffer from these crippling illnesses. Oxycodone hydrochloride is a crucial treatment choice for delivering perpetual pain reduction, especially in its extended-release development.
However, the growing popularity of the worldwide oxycodone hydrochloride sector is expected to face significant obstacles in the years ahead due to stringent government regulations pertaining to the prescriptions and usage of the medication for individuals seeking pain treatment. A number of adverse consequences brought on by using these medications may make the industry's expansion even more difficult. The COVID-19 epidemic has affected the market, leading to the shutdown of multiple firms to prevent viral transmission among employees. This could impede the industry's growth.
The oxycodone hydrochloride market is segmented based on type, route of administration, and distribution channel. Based on type, the market includes into controlled-release and immediate-release. The route of administration segment comprises oral and parenteral. By distribution channel, the market consists of hospital pharmacies, retail pharmacies, and online pharmacies.
The controlled-release oxycodone hydrochloride market will hold a major global market share, because of its capacity to regulate the absorption of oxycodone hydrochloride medications, which are used to treat individuals' extreme to significant pain. Furthermore, because of the increasing harm, distraction, and overuse of oxycodone hydrochloride, the medication's-controlled release is supported. Also, the growing demand for oxycodone hydrochloride's-controlled release rather than its instant distribution for chemotherapy patients' pain management will support the segment's growth.
The hospital pharmacy industry uses bulk oxycodone hydrochloride because hospitals play an important role in helping patients with a variety of pain-related disorders, including cancer, recovery from surgical procedures, and persistent diseases. As a result, there is an immense need for oxycodone pills in hospital settings, where doctors frequently provide them to treat severe and persistent pain. Furthermore, oxycodone's strict regulation and restricted nature call for careful surveillance and supervision, which are easily accessible in a hospital-controlled setting.
The North American oxycodone hydrochloride market is predicted to record the highest market revenue share in the near future. This can be attributed to the widespread use of cutting-edge healthcare technologies and systems. Concerns about infectious diseases in the elderly and cost-effective detection are other factors driving demand for the product, and these factors are expected to persist throughout the forecast duration. In addition, Europe is projected to grow very fast in the global oxycodone hydrochloride industry because of the growth of a more advanced medical system and an upsurge in the regular individual's financial resources. Additionally, the market is expanding more quickly due to rising awareness of customized medications and the creation of oxycodone hydrochloride startups.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 412.4 Mn |
|
Revenue Forecast In 2031 |
USD 572.8 Mn |
|
Growth Rate CAGR |
CAGR of 4.33% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Type, Route Of Administration, And Distribution Channel |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Eli Lilly and Company, Gilead Sciences, Inc., Manus Aktteva Biopharma LLP, Arevipharma GmbH, Saneca Pharma a.s., Cipla Ltd., Noramco, Inc., MacFarlan Smith, Teva Pharmaceutical Industries Ltd., Taj Pharma, Chattem Chemicals Inc, Mayne Pharma Group Ltd., Dr. Reddy’s Laboratories Limited, Siegfried, Rhodes Pharmaceuticals L.P., Mallinckrodt Pharmaceuticals, Johnson & Johnson, Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Limited, Lupin Limited, and Sanofi S.A. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oxycodone Hydrochloride Market Snapshot
Chapter 4. Global Oxycodone Hydrochloride Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Oxycodone Hydrochloride Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Oxycodone Hydrochloride Industry Trends
Chapter 5. Oxycodone Hydrochloride Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type:
5.2.1. Controlled-Release
5.2.2. Immediate-Release
Chapter 6. Oxycodone Hydrochloride Market Segmentation 2: By Route of Administration, Estimates & Trend Analysis
6.1. Market Share by Route of Administration, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Route of Administration:
6.2.1. Oral
6.2.2. Parenteral
Chapter 7. Oxycodone Hydrochloride Market Segmentation 3: By Distribution Channel, Estimates & Trend Analysis
7.1. Market Share by Distribution Channel, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Distribution Channels:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Oxycodone Hydrochloride Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Oxycodone Hydrochloride Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.2.3. North America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
8.2.4. North America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.3. Europe
8.3.1. Europe Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.3.3. Europe Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
8.3.4. Europe Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.4. Asia Pacific
8.4.1. Asia Pacific Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.4.3. Asia Pacific Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts By Route of Administration, 2019-2031
8.4.4. Asia Pacific Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.5. Latin America
8.5.1. Latin America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.5.3. Latin America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
8.5.4. Latin America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.6.3. Middle East & Africa Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
8.6.4. Middle East & Africa Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Eli Lilly and Company
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Gilead Sciences, Inc.
9.2.3. Manus Aktteva Biopharma LLP
9.2.4. Arevipharma GmbH
9.2.5. Saneca Pharma a.s.
9.2.6. Cipla Ltd.
9.2.7. Noramco, Inc.
9.2.8. MacFarlan Smith
9.2.9. Teva Pharmaceutical Industries Ltd.
9.2.10. Taj Pharma
9.2.11. Chattem Chemicals Inc
9.2.12. Mayne Pharma Group Ltd.
9.2.13. Dr. Reddy’s Laboratories Limited
9.2.14. Siegfried
9.2.15. Rhodes Pharmaceuticals L.P.
9.2.16. Mallinckrodt Pharmaceuticals
9.2.17. Johnson & Johnson
9.2.18. Bristol-Myers Squibb Company
9.2.19. Sun Pharmaceutical Industries Limited
9.2.20. Lupin Limited
9.2.21. Sanofi S.A.
9.2.22. Other Prominent Players
Oxycodone Hydrochloride Market By Type-
Oxycodone Hydrochloride Market By Route of Administration-
Oxycodone Hydrochloride Market By Distribution Channel-
Oxycodone Hydrochloride Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
